Do Kim is a Head of Strategy - Human Data, R and D Data Strategy at Amgen. He possess expertise in drug delivery, entrepreneurial leadership, venture capital, product management, mobile technology and 23 more skills. Colleagues describe him as "I have known Do since 2009 when we worked together at Medtronic. Do is an intensely curious person with a strong entrepreneurial spirit. With Do I could always count on insightful input that cut to the heart of an issue. Over the years we have debated many subjects and I have always valued his deep technical expertise particularly in the ever changing medical device digital and mobile spaces. I would strongly recommend Do to anyone who is looking for a strategic thinker that is also capable of action; a rare combination these days.", "Do stands out as an extraordinary collaborator because of his skills diversity. He was a very enthusiastic project manager who was able to vision and help advance new user experiences in mobile applications. Perfectly able to drive and push multidisciplinary team, overseeing all software/hardware specificities, including managing developers, vendors, software discipline and regulation compliance. Mastering such a diverse skill-set is exceptional when indeed, the vast majority of engineers stay in their confort zone and focus on a specific set of technologies. He understands how to use state of the art tech and processes, with the right touch or appetence for risk that can lead to success. Still in ambiguous environment he creates value, at a core very entrepreneurial. Especially since on top of that he has an intuitive understanding of the revolution that is happening actually in our industry. I had great pleasure working with Do for a variety of reasons, many thought discussions over human centered design, design theories and trends. As such, he embodies the definition of ‘A-class’ in his field, I hope to work with him again.", and "Do worked as an undergraduate researcher in my lab in the Department of Chemistry and Biochemistry at the University of California, San Diego from 2002-2004. Do’s work in my lab resulted in 2 publications (“Intravitreal properties of porous silicon photonic crystals: a potential self-reporting intraocular drug delivery vehicle.” Br. J. Ophthalmol. 2008, 92, 705; and “Intraocular properties of silicon photonic crystals for intravitreal drug delivery and sensing.” Investigative Ophthalmology & Visual Science 2005, 46). A hallmark characteristic of Do’s personality was his dedication despite numerous setbacks. Do helped initiate my now longstanding collaboration with Dr. Bill Freeman at the UCSD Jacobs Retina Center. He prepared the first porous Si samples that went into live rabbit eyes and assisted with the first human eye experiments, demonstrating the possibility of using such materials in intraocular drug delivery. This concept is now being actively pursued in many academic and pharmaceutical labs worldwide. Do is a hard worker and he picks up on concepts quickly. He has a solid sense of personal integrity, and I could always trust his results. Due to his strong interpersonal skills, I asked Do to take on the role of “group coordinator” toward the end of his time in my lab. His duties included coordinating the scheduling of group meetings, arranging occasional group parties, and keeping tabs on various laboratory supplies and equipment. Do performed in this role very effectively. He has excellent presentation skills, and gave several well-received talks at local and international meetings as well as in my weekly research group meetings."